| Literature DB >> 29211019 |
Sushovan Dam1, Jean-Marie Pagès2, Muriel Masi3.
Abstract
Antibiotic resistant Gram-negative bacteria are a serious threat for public health. The permeation of antibiotics through their outer membrane is largely dependent on porin, changes in which cause reduced drug uptake and efficacy. Escherichia coli produces two major porins, OmpF and OmpC. MicF and MicC are small non-coding RNAs (sRNAs) that modulate the expression of OmpF and OmpC, respectively. In this work, we investigated factors that lead to increased production of MicC. micC promoter region was fused to lacZ, and the reporter plasmid was transformed into E. coli MC4100 and derivative mutants. The response of micC-lacZ to antimicrobials was measured during growth over a 6 h time period. The data showed that the expression of micC was increased in the presence of β-lactam antibiotics and in an rpoE depleted mutant. Interestingly, the same conditions enhanced the activity of an ompN-lacZ fusion, suggesting a dual transcriptional regulation of micC and the quiescent adjacent ompN. Increased levels of OmpN in the presence of sub-inhibitory concentrations of chemicals could not be confirmed by Western blot analysis, except when analyzed in the absence of the sigma factor σE. We suggest that the MicC sRNA acts together with the σE envelope stress response pathway to control the OmpC/N levels in response to β-lactam antibiotics.Entities:
Keywords: Escherichia coli; antibiotic susceptibility; membrane transport; outer membrane porins; regulatory small RNAs
Year: 2017 PMID: 29211019 PMCID: PMC5745476 DOI: 10.3390/antibiotics6040033
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1(a) Dose dependent micC–lacZ activity in presence of increasing concentrations of biapenem (MIC of 0.32 µg/mL); (b) β-galactosidase activity of the micC- and ompN-lacZ fusions in the presence of selected compounds. Values are means from three independent determinations, and standard deviation is represented.
Figure 2Western blot (WB) analysis of outer membrane (OM) proteins. Cells were grown, and OM extracts were prepared as described in the Materials and Methods. OM proteins equivalent to 0.2 OD600 units of cultures were separated by SDS-PAGE, electrotransferred on nitrocellulose membranes, and blotted with the appropriate anti-sera. Data show the production of OmpC (a) and OmpN (b). Both the positive controls pDrive-micC and pTrc99A-ompN were induced by 0.4 mM IPTG for 3 h. TolC expression was used for normalizing sample loading, and the expression of normalized OmpC has been expressed in mean values from three independent experiments.
Figure 3(a) β-Galactosidase activity of the micC– and ompN–lacZ fusions in different genetic backgrounds. Envelope stress sigma factor σE is essential in Escherichia coli. Therefore, cells were temporarily depleted of σE by the overexpression of the anti-sigma factor RseA with 0.4 mM IPTG under heat shock conditions at 42 °C; (b) WB analysis of OM proteins. Cells were grown, and OM extracts were prepared as described in the Materials and Methods. OM proteins equivalent to 0.2 ODU of cultures were separated by SDS-PAGE, electrotransferred on nitrocellulose membranes, and blotted with the appropriate anti-sera. Data show the production of OmpC (upper panel) and OmpN (lower panel). TolC expression was evaluated for normalizing sample loading and the expression of normalized OmpC has been expressed in numerical values below the bands; (c) β-galactosidase activity of a degP–lacZ chromosomal fusion in response to various external stresses.
Figure 4Metabolic inhibition of intact cells expressing OmpF, OmpC, or OmpN in the presence of selected β-lactam antibiotics using a resazurin-reduction-based assay. Actively metabolizing bacterial cells are able to reduce blue resazurin into red resofurin, which emits fluorescence at 590 nm. The experiment was performed in a microtiter plate, and fluorescence was measured every 10 min with an excitation wavelength of 530 nm and an emission wavelength of 590 nm. Inhibition of resazurin reduction in the presence of appropriate concentrations of each antibiotic was translated into % metabolic inhibition.
Strains and plasmids used in this study.
| Strain or Plasmid | Description | Source or Reference |
|---|---|---|
| MC4100 | F−
| [ |
| MH1160 | MC4100 | [ |
| TR49 | MC4100 λRS88[ | [ |
| W3110 | F−
| [ |
| SR8265 | W3110 | [ |
| PS2209 | W3110 Δ | [ |
| PS2652 | Δ | [ |
| AG100 | F−
| [ |
| CH164 | AG100 | [ |
| BW25113 | F− Δ | [ |
| JW4130 | BW25113 | GE Healthcare |
| SD01 | MC4100 Δ | This study |
| SD02 | MC4100 | This study |
| SD03 | MC4100 Δ | This study |
| SD04 | MC4100 Δ | This study |
| SD05 | MC4100 Δ | This study |
| W3110Δ | W3110 | M.G. Page |
| W3110Δ | W3110 | M.G. Page |
| W3110Δ | W3110 Δ | M.G. Page |
| Plasmids | ||
| pDrive | PCR cloning vector; AmpR, KanR | Qiagen |
| pRC1 | pDrive containing | [ |
| pRC2 | pDrive containing | [ |
| pSD01 | pDrive encoding MicC sRNA | This study |
| pFus2K | Cloning vector with promoter-less | [ |
| pSD02 | pFus2K containing the | This study |
| pSD03 | pFus2K containing the | This study |
| pTrc99A | Expression vector with the inducible PTRC promoter, AmpR | Pharmacia |
| pSD04 | pTrc99A containing OmpN | This study |
| pSD05 | pTrc99A containing RseA | This study |
| pBAD24 | Expression vector with the inducible PBAD promoter, AmpR | [ |
| pBAD24-NlpE | pBAD24 containing NlpE | M. Masi |
| pBAD33 | Expression vector with the inducible PBAD promoter, CamR | [ |
| pBAD33-CpxA* | pBAD33 containing an autoactivated (*) CpxA | M. Masi |